The approval of EXUBERA, the first inhaled insulin, in the States back in Jan 2006 was certainly an exuberant milestone in the treatment of diabetes. For many, the insulin powder to be taken via inhalation was the long-awaited replacement for painful insulin injections that many diabetics need. However, the exuberance came to an end in 18 Oct 2007 when Pfizer announced that it would no longer be making EXUBERA, largely due to poor sales. Check out the external links below to find out more.


EXUBERA stand at EASD annual meeting, Amsterdam (09/2007)

Related links:

• Pfizer: Exubera
  
• Nature Biotechnology: Pfizer dumps Exubera
  
• Forbes: Pfizer washes its hands of Exubera
  
• Businessweek: Pfizer's exubernat Ad rollout
  

Tags: Science